Steroids In caRdiac Surgery Trial (SIRS Trial)
|ClinicalTrials.gov Identifier: NCT00427388|
Recruitment Status : Unknown
Verified July 2014 by Richard Whitlock, McMaster University.
Recruitment status was: Active, not recruiting
First Posted : January 29, 2007
Last Update Posted : August 4, 2014
Population Health Research Institute
Canadian Institutes of Health Research (CIHR)
Information provided by (Responsible Party):
Richard Whitlock, McMaster University
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Primary Completion Date :||February 2014|
|Estimated Study Completion Date :||August 2014|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Thériault S, Whitlock R, Raman K, Vincent J, Yusuf S, Paré G. Gene Expression Profiles for the Identification of Prevalent Atrial Fibrillation. J Am Heart Assoc. 2017 Jun 30;6(7). pii: e006057. doi: 10.1161/JAHA.117.006057.
Whitlock RP, Devereaux PJ, Teoh KH, Lamy A, Vincent J, Pogue J, Paparella D, Sessler DI, Karthikeyan G, Villar JC, Zuo Y, Avezum Á, Quantz M, Tagarakis GI, Shah PJ, Abbasi SH, Zheng H, Pettit S, Chrolavicius S, Yusuf S; SIRS Investigators. Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial. Lancet. 2015 Sep 26;386(10000):1243-1253. doi: 10.1016/S0140-6736(15)00273-1.